Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500 GlobeNewswire - Tue Oct 29, 8:05AM CDT

PACB : 2.44 (+12.44%)
PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program GlobeNewswire - Tue Oct 22, 8:05AM CDT

PACB : 2.44 (+12.44%)
PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing GlobeNewswire - Fri Oct 11, 8:05AM CDT

PACB : 2.44 (+12.44%)
PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024 GlobeNewswire - Thu Oct 10, 3:05PM CDT

PACB : 2.44 (+12.44%)
Pacific Biosciences: Q2 Earnings Snapshot AP - Wed Aug 7, 5:10PM CDT

Pacific Biosciences: Q2 Earnings Snapshot

PACB : 2.44 (+12.44%)
Pacific Biosciences: Q1 Earnings Snapshot AP - Thu May 9, 4:04PM CDT

Pacific Biosciences: Q1 Earnings Snapshot

PACB : 2.44 (+12.44%)
Pacific Biosciences: Q4 Earnings Snapshot AP - Thu Feb 15, 3:28PM CST

Pacific Biosciences: Q4 Earnings Snapshot

PACB : 2.44 (+12.44%)
Pacific Biosciences: Q3 Earnings Snapshot AP - Mon Oct 30, 2023

Pacific Biosciences: Q3 Earnings Snapshot

PACB : 2.44 (+12.44%)
Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy? Motley Fool - Wed Oct 18, 2023

This innovator is targeting a huge, rapidly growing market.

PACB : 2.44 (+12.44%)
ARKK : 46.64 (+1.63%)
ARKG : 24.00 (+3.72%)
PacBio Announces Appointment of David Meline to Board of Directors PR Newswire - Mon Oct 16, 2023

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David...

PACB : 2.44 (+12.44%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy Barchart - Sat Nov 2, 10:15AM CDT
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot